The European Tribune is a forum for thoughtful dialogue of European and international issues. You are invited to post comments and your own articles.
Please REGISTER to post.
AstraZeneca says it will boost vaccine production to 2M a week | Politico - Jan. 15, 2021 | Health authorities in the UK have decided to change their distribution strategy, prioritizing giving as many people a first shot as possible. British drugmaker AstraZeneca says it will boost production of the coronavirus vaccine it developed with Oxford University to two million doses a week by the middle of January. According to the Times, an unnamed member of the Oxford/AstraZeneca team said production was expected to reach a total of 1 million doses by the end of next week. "The plan is then to build it up fairly rapidly -- by the third week of January we should get to two million a week," they added. ... Meanwhile, a senior scientist from Oxford University has complained that the country's pharmaceutical manufacturing base is not prepared to handle the roll-out of the jab. "The government has been completely disinterested in building onshore manufacturing capacity for any of the life-sciences products," said John Bell, professor of medicine at Oxford.
Health authorities in the UK have decided to change their distribution strategy, prioritizing giving as many people a first shot as possible.
British drugmaker AstraZeneca says it will boost production of the coronavirus vaccine it developed with Oxford University to two million doses a week by the middle of January.
According to the Times, an unnamed member of the Oxford/AstraZeneca team said production was expected to reach a total of 1 million doses by the end of next week.
"The plan is then to build it up fairly rapidly -- by the third week of January we should get to two million a week," they added.
...
Meanwhile, a senior scientist from Oxford University has complained that the country's pharmaceutical manufacturing base is not prepared to handle the roll-out of the jab.
"The government has been completely disinterested in building onshore manufacturing capacity for any of the life-sciences products," said John Bell, professor of medicine at Oxford.
Simple math ... manufacturing rate of 52 million per year to double to 104 million 🚱 ... cutting corners to please the Brexiteers in the City.
Update on the vaccine supply issues & confusing govt lines on this 1/2 @ks_1968 [_link]— Sarah Rosemary (@SarahRosemary3) January 2, 2021
Update on the vaccine supply issues & confusing govt lines on this 1/2 @ks_1968 [_link]
by Luis de Sousa - Feb 28 1 comment
by IdiotSavant - Feb 28
by Oui - Mar 1 1 comment
by Frank Schnittger - Feb 23 15 comments
by Oui - Feb 22 19 comments
by Oui - Feb 25
by Frank Schnittger - Feb 20 16 comments
by gmoke - Feb 14 2 comments
by Oui - Mar 11 comment
by gmoke - Mar 1
by Luis de Sousa - Feb 281 comment
by Oui - Feb 2827 comments
by Frank Schnittger - Feb 2315 comments
by Oui - Feb 2219 comments
by Frank Schnittger - Feb 2016 comments
by Oui - Feb 2021 comments
by Frank Schnittger - Feb 1914 comments
by Oui - Feb 197 comments
by Oui - Feb 18
by Oui - Feb 1787 comments
by Oui - Feb 168 comments
by Frank Schnittger - Feb 1523 comments
by gmoke - Feb 142 comments
by Frank Schnittger - Feb 1413 comments
by Oui - Feb 145 comments
by Oui - Feb 1245 comments